Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

K Westerlund; M Altai; B Mitran; Mark Konijnenberg; M Oroujeni; C Atterby; Marion Jong; A Orlova; J Mattsson; P Micke; AE Karlstrom; V Tolmachev

doi:10.2967/jnumed.118.208348

Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

K Westerlund
, M Altai
, B Mitran
, Mark Konijnenberg
, M Oroujeni
, C Atterby
, Marion Jong
, A Orlova
, J Mattsson
, P Micke
, AE Karlstrom
, V Tolmachev

Radiology & Nuclear Medicine

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1092-1098
Number of pages	7
Journal	Journal of Nuclear Medicine
Volume	59
Issue number	7
DOIs	https://doi.org/10.2967/jnumed.118.208348
Publication status	Published - 2018

Research programs

EMC MM-01-40-01
EMC NIHES-03-30-02

Access to Document

10.2967/jnumed.118.208348

http://hdl.handle.net/1765/109184

Cite this

Westerlund, K., Altai, M., Mitran, B., Konijnenberg, M., Oroujeni, M., Atterby, C., Jong, M., Orlova, A., Mattsson, J., Micke, P., Karlstrom, AE., & Tolmachev, V. (2018). Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle. Journal of Nuclear Medicine, 59(7), 1092-1098. https://doi.org/10.2967/jnumed.118.208348

@article{1c5418f543f547a8a6758e5fdefe0e56,

title = "Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle",

author = "K Westerlund and M Altai and B Mitran and Mark Konijnenberg and M Oroujeni and C Atterby and Marion Jong and A Orlova and J Mattsson and P Micke and AE Karlstrom and V Tolmachev",

year = "2018",

doi = "10.2967/jnumed.118.208348",

language = "Undefined/Unknown",

volume = "59",

pages = "1092--1098",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "7",

}

Westerlund, K, Altai, M, Mitran, B, Konijnenberg, M, Oroujeni, M, Atterby, C, Jong, M, Orlova, A, Mattsson, J, Micke, P, Karlstrom, AE & Tolmachev, V 2018, 'Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle', Journal of Nuclear Medicine, vol. 59, no. 7, pp. 1092-1098. https://doi.org/10.2967/jnumed.118.208348

TY - JOUR

T1 - Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

AU - Westerlund, K

AU - Altai, M

AU - Mitran, B

AU - Konijnenberg, Mark

AU - Oroujeni, M

AU - Atterby, C

AU - Jong, Marion

AU - Orlova, A

AU - Mattsson, J

AU - Micke, P

AU - Karlstrom, AE

AU - Tolmachev, V

PY - 2018

Y1 - 2018

U2 - 10.2967/jnumed.118.208348

DO - 10.2967/jnumed.118.208348

M3 - Article

C2 - 29439013

SN - 0161-5505

VL - 59

SP - 1092

EP - 1098

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 7

ER -